Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities.

Klein, Elizabeth J; Hardesty, Anna; Vieira, Kendra; Farmakiotis, Dimitrios

Klein, Elizabeth J; Hardesty, Anna; Vieira, Kendra; Farmakiotis, Dimitrios.

Afiliação

Klein EJ; Division of Infectious Diseases, Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Hardesty A; Division of Infectious Diseases, Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Vieira K; Internal Medicine Residency Program, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Farmakiotis D; Division of Infectious Diseases, Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Am J Transplant ; 22(2): 640-645, 2022 02.

Article em En | MEDLINE | ID: mdl-34591350

Assuntos

COVID-19; Transplante de Rim; Anticorpos Monoclonais/uso terapêutico; Humanos; Transplante de Rim/efeitos adversos; Pandemias; SARS-CoV-2; Transplantados

Palavras-chave

health services and outcomes research; infection and infectious agents-viral; infectious disease; kidney transplantation/nephrology; patient survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Transplante de Rim / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Transplant Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google